Updates An Italian study has found that the use of the bone drug Fosamax by young patients with low bone density and cystic fibrosis can help with bone quality. RLG which maintains a Fosamax lawsuit information website athttp://www.rotlaw.com/fosamax acknowledges the study’s results but notes that other studies show the use of Fosamax can also… Read more
A New Jersey jury ruled in favor of pharmaceutical company Merck in a Fosamax femur fracture trial in Trenton on April 29. RLG which represents clients in Fosamax lawsuits encourages those who seek to file lawsuits to continue to do so despite the ruling in what was considered a bellwether trial for Fosamax femur… Read more
As a new Fosamax femur fracture trial proceeds in Trenton N.J. the jury has heard from the plaintiff’s lawyer that manufacturer Merck knew about bone injury risks associated with Fosamax at least five years before the U.S. Food and Drug Administration approved the drug. The lawyer for plaintiff Bernadette Glynn told a… Read more
A new Fosamax leg injury trial begins in Trenton N.J. on April 9. The plaintiff fell in her driveway and broke her femur. She alleges that seven years of Fosamax use put her thigh at risk for the fracture. According to Bloomberg Bernadette Glynn of Cohoes N.Y. suffered… Read more
The first trial to consider claims that Merck hid the alleged bone-weakening femur-fracturing side effects of Fosamax ended abruptly this week after plaintiff Christina Su 67 suffered a heart attack and New Jersey Superior Court Judge Carol E. Higbee declared a mistrial. Su was deemed not fit enough to endure a… Read more
The first trial to feature claims that Merck hid the alleged bone-weakening femur-fracturing side effects of Fosamax began this week. Christina Su 67 filed the Fosamax lawsuit against Merck in New Jersey Superior Court. RLG a Fosamax law firm is monitoring this trial via numerous sources. Opening… Read more
The possible femur-fracturing side effects of Fosamax have been known for years. But RLG acknowledges with concern a new study from the Journal of Bone & Joint Surgery that further reinforces the link between the drug and fractures that don’t heal. RLG which represents clients in Fosamax lawsuits maintains a website that provides a history… Read more
The Rottenstein Law Group which accepts clients who wish to file Fosamax injury lawsuits is encouraged by the Feb. 5 report of a $285 000 verdict against Merck in a New York trial over the drug Fosamax which has been found to weaken bones and cause jaw death. According… Read more
As the new year begins the Rottenstein Law Group prepares to closely follow a Jan. 14 Fosamax bellwether trial in New York. Patients have filed many Fosamax lawsuits related to the osteoporosis drug’s serious side effects such as osteonecrosis of the jaw (ONJ) the so-called “Dead Jaw ” and femur… Read more
As Fosamax lawsuits mount because of the drug’s serious side effects sales of the drug for manufacturer Merck have fallen by as much as 80 percent in the past decade. A third quarter earnings report for 2012 for Merck showed sales from Fosamax were around $700 million down from a… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax is taking all necessary measures to comply with the latest order of the federal Fosamax MDL court. As the United States District Court for the Southern District of New York prepares… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax has learned that Merck & Co. Inc. believes it has in odanacatib a replacement for the embattled osteoporosis drug almost ready for release. Spontaneous fractures related to Fosamax usually occur when… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax stresses that a confidential agreement on damages between Merck and an ONJ victim does not moot a jury’s verdict finding the company liable for the claimant’s injuries. The parties in Boles… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax has learned that the manufacturer of the embattled drug Fosamax has reached an agreement with the estate of a plaintiff harmed by the blockbuster bone drug. According to a report filed… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax has learned that researchers have concluded that many Americans who take oral steroids are not also taking steps to reduce the side effects of those drugs—even if one of those steps is taking the… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax has learned that researchers have found a link between the drug and cancer of the esophagus. A study recently presented to the 2012 American Society of Clinical Oncology Annual Meeting concludes… Read more
The Rottenstein Law Group has learned that the first New Jersey court trials of cases involving femur fractures caused by the drug will happen before further trials of cases involving other harms. By letter dated June 4 2012 Superior Court of New Jersey Judge Carol E. Higbee informed lawyers for… Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax has learned that the FDA has published an analysis generally recommending caution when using popular bone-building medications for long terms though without offering more specific suggestions. The agency’s analysis … Read more
The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax is disheartened to learn that manufacturer Merck is claiming victory in a fifth lawsuit. In a press release dated April 18 Merck & Co. Inc manufacturer of the… Read more
The Rottenstein Law Group is dismayed to learn that first-time users have an increased chance of developing certain inflammatory eye disorders while taking Fosamax to combat osteoporosis. Researchers at the Child and Family Research Institute at the University of British Columbia in Vancouver looked at over 934 000 people who visited ophthalmologists… Read more
